Send Message
Contact Us

Contact Person : Jimmy Tian

Phone Number : 86-18602905046

WhatsApp : +8618602905046

Free call

Detail Information

Country Of Origin: India Pack Size: 1 Vial
Storage Conditions: Store At Room Temperature Warnings: Do Not Use In Pregnant Or Breastfeeding Women
Contraindications: Hypersensitivity To The Active Substance Or To Any Of The Excipients Indication: Treatment Of Hormone Receptor-positive Metastatic Breast Cancer
Shelf Life: 36 Months Manufacturer: Pfizer
High Light:

Fulvestrant Pharmaceutical Intermediates

,

1 Vial Pack Fulvestrant Injection

,

Breast Cancer Treatment Fulvestrant Injection

Product Description

Product Description:

Fulvestrant Injection, also known as Faslodex Injection, is a product of Pfizer, a world-leading research-based pharmaceutical company. This injection contains Fulvestrant, which is an estrogen receptor antagonist used in the treatment of postmenopausal women with advanced or metastatic breast cancer. It is effective in reducing the progression of certain types of breast cancer. However, it should not be used in pregnant or breastfeeding women and people with hypersensitivity to the active substance or to any of the excipients.

This injection needs to be stored at room temperature and should be administered by a healthcare professional. Common adverse reactions to Fulvestrant Injection include nausea, vomiting, fatigue, headache, hot flashes, bone pain, arthralgia, myalgia, and anorexia. It is important to talk to a doctor before taking this injection to make sure it is safe to use.

 

Features:

  • Product Name: Fulvestrant
  • Strength: 500mg/5ml
  • Pack Size: 1 Vial
  • Storage Conditions: Store At Room Temperature
  • Shelf Life: 36 Months
  • Adverse Reactions: Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia
 

Technical Parameters:

Product Name Fulvestrant
Active Ingredient Fulvestrant
Form Injection
Dosage 250mg Intramuscularly Once Every 28 Days
Indication Treatment Of Hormone Receptor-positive Metastatic Breast Cancer
Manufacturer Pfizer
Country of Origin India
Shelf Life 36 Months
Adverse Reactions Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia
Contraindications Hypersensitivity To The Active Substance Or To Any Of The Excipients
 

Applications:

Fulvestrant is a faslodex injection from India with a pack size of 1 Vial. It is indicated for the treatment of hormone receptor-positive metastatic breast cancer. Contraindications include hypersensitivity to the active substance or to any of the excipients.

Fulvestrant is used to treat advanced forms of hormone receptor-positive breast cancer, which means the cancer cells are stimulated by the hormone estrogen. It works by blocking the effects of estrogen on the cancer cells and reducing their growth. Fulvestrant is usually used after other treatments, such as endocrine therapy, have failed.

Fulvestrant is also used to treat postmenopausal women with advanced disease and those who have not previously been treated with endocrine therapy. It is given as an intramuscular injection every 28 days for up to a year or more. It is important to follow your doctor's instructions for taking this medication.

Fulvestrant is a powerful medication and should only be used when other treatments have failed. It is important to discuss the risks and benefits of treatment with your doctor before starting Fulvestrant.

 

Support and Services:

Fulvestrant technical support and service provides customers with the necessary information and tools to help them properly use Fulvestrant. Technical support is available through email, phone, and online chat. Customers can also access detailed product documentation, including FAQs and installation instructions. Additionally, Fulvestrant provides a wide range of customer service services, such as warranty coverage, product training, and customer satisfaction surveys.

 

FAQ:

  • Q: What is Fulvestrant?
  • A: Fulvestrant is a prescription medicine used to treat hormone receptor-positive advanced or metastatic breast cancer in postmenopausal women.
  • Q: How does Fulvestrant work?
  • A: Fulvestrant is an estrogen receptor antagonist. It works by blocking the effects of estrogen in the body, which can interfere with the growth of certain types of breast cancer.
  • Q: Who should take Fulvestrant?
  • A: Fulvestrant is indicated for postmenopausal women with hormone receptor-positive advanced or metastatic breast cancer. Your doctor will determine if Fulvestrant is right for you.
  • Q: What are the possible side effects of Fulvestrant?
  • A: Common side effects of Fulvestrant include: joint pain, nausea, vomiting, hot flashes, and headache. Tell your doctor if you have any side effect that bothers you or does not go away.
  • Q: How should Fulvestrant be administered?
  • A: Fulvestrant should be administered as an intramuscular injection. Your doctor or healthcare provider will provide you with specific instructions on how to administer the medication.

You Might Be Into These
Get in touch with us

Enter Your Message

sales@libang.com.cn
+8618089290889